`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`ARKEMA AND ARKEMA FRANCE
`Petitioner,
`v.
`
`HONEYWELL INTERNATIONAL INC.,
`Patent Owner.
`
`
`
`Case No.: PGR2016-00011
`Patent No.: 9,157,017
`
`
`PATENT OWNER’S OBSERVATIONS ON
`
`STATEMENTS IN PETITIONER’S REPLY
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to the Board’s Order (Paper 39), Patent Owner submits these
`
`observations on statements in Arkema’s Reply (Paper 31).
`
`Mischaracterization of Mexichem White Paper as Discussing Automobile Air
`
`Conditioning in 1997
`
`At page 2 lines 2-11 of its Reply Arkema mischaracterizes the Mexichem
`
`White Paper (Ex. 2071).
`
`Mischaracterization of Its Own Patent Application as Unrelated to
`
`Automobile Air Conditioning Stability
`
`At page 16 line 10 through page 17 line 8 of its Reply Arkema
`
`mischaracterizes the prosecution history of its patent application (Ex. 2069).
`
`Mischaracterization of Dr. DesMarteau as Not Considering End-Capping
`
`At page 14 line 15 through page 15 line 6 of its Reply Arkema
`
`mischaracterizes Dr. DesMarteau’s declaration (Ex. 2161 ¶ 41) and deposition
`
`testimony (Ex. 1178 at 42:18-22; 43:13-19).
`
`Mischaracterization of Dr. DesMarteau’s Testimony as Expecting Short
`
`Free-Radical Lifetimes
`
`At page 15 lines 14-17 of its Reply Arkema mischaracterizes Dr.
`
`DesMarteau’s deposition testimony (Ex. 1178 at 45:10-50:7).
`
`
`
`1
`
`
`
`
`
`Mischaracterization of Dr. DesMarteau’s Testimony Regarding Dimerization
`
`At page 15 line 18 through page 16 line 6 of its Reply Arkema
`
`mischaracterizes Dr. DesMarteau’s declaration (Ex. 2161 ¶ 31) and deposition
`
`testimony (Ex. 1178 at 12:11-12:2; 28:23-29:11).
`
`Mischaracterization of the Banks Article
`
`At page 19 lines 3-9 of its Reply Arkema mischaracterizes the Banks article
`
`(Ex. 1169).
`
`Mischaracterization of Dr. Whittaker as Not Being a POSITA
`
`At page 20 lines 16-18 of its Reply Arkema mischaracterizes Dr.
`
`Whittaker’s deposition testimony (Ex. 1176 at 93:16-95:7).
`
`Mischaracterization of Dr. DesMarteau’s Expertise
`
`At page 13 lines 5-10 of its Reply Arkema mischaracterizes Dr.
`
`DesMarteau’s expertise (Ex. 1178 at 5:23-7:3; 36:10-37:11).
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`
`
`Date: April 12, 2017
`
`Eugene Goryunov (Reg. No. 61,579)
`egoryunov@kirkland.com
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, Illinois 60654
`Telephone: (312) 862-2000
`Fax: (312) 862-2200
`
`Respectfully submitted,
`
`/s/ Gregg F. LoCascio, P.C.
`
`Gregg F. LoCascio, P.C. (Reg. No. 55,396)
`Noah Frank (Reg. No. 67,279)
`glocascio@kirkland.com
`noah.frank@kirkland.com
`KIRKLAND & ELLIS LLP
`655 Fifteenth Street, NW
`Suite 1200
`Washington, DC 20005
`Telephone: (202) 879-5200
`Fax: (202) 879-5200
`
`Attorneys For Patent Owner
`
`
`
`
`
`
`
`
`
`3
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Observations on Statements in Petitioner’s Reply on April 12, 2017, via
`
`electronic mail directed to counsel of record for the Petitioners:
`
`Mark D. Sweet
`Mark J. Feldstein
`Erin M. Sommers
`Charles W. Mitchell
`
`
`mark.sweet@finnegan.com
`mark.feldstein@finnegan.com
`erin.sommers@finnegan.com
`charles.mitchell@finnegan.com
`Arkema_PTAB@finnegan.com
`
`
`
`
`
`/s/ Gregg F. LoCascio, P.C.
`Gregg F. LoCascio, P.C.
`
`
`
`
`
`4
`
`